Certified by Founder Lodge
Syntis Bio
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $38,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide accessible, effective and sustainable solutions
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 02 ,2025 | Series A | $38,000,000 |
BOLD Capital Partners
Safar Partners
Portal Innovations, LLC
Cerberus Capital Management
Woori Venture Partners US
Cerity Partners Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Revel(US) | $150,000,000 | (Feb 27, 2026)
Bluprynt | $4,250,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)